Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 312 participants.
Also called NCT07273994
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 312 participants
- Sponsor
- Registry
-
NCT07273994 -
2024-514113-35-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07273994. Randomized; no masking; primary purpose treatment. Start 2025-11-01 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
- Acronym
- PERIVERSION-2
- Condition
- Persistent Atrial Fibrillation
- Intervention (Drug)
- Amiodarone Hydrochloride 200 MG
- Intervention (Drug)
- Amiodarone Hydrochloride 100 MG
- Lead sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Collaborator
- Instituto de Salud Carlos III
Record details
- Record id
cardio:ct-nct07273994- Content hash
64499a8a074d05b3b81b95b70be1968bfcb386c016614db3c09cfadd5d45759a